EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach

Angelo Del Gaudio, Federica Di Vincenzo iD, Valentina Petito iD, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri iD, Loris Riccardo Lopetuso

Inflammatory Bowel Diseases · 03.06.2024 · 30 (6) · 1018-1031

DOI: 10.1093/ibd/izad229 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 06.10.2023. Verfasst von Angelo Del Gaudio und 6 weiteren Autor:innen. Beteiligte Einrichtung: UOS Malattie Infiammatorie Croniche Intestinali, Centro di Malattie dell'Apparato Digerente (CEMAD), Fondazione Policlinico Universitario A. Gemelli …. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Colitis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, antitumor immunotherapies have witnessed a breakthrough with the emergence of immune checkpoint inhibitors (ICIs) including programmed cell death-1 (PD-1), programmed cell death-ligand 1 (PD-L1), and cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibitors. Unfortunately, the use of ICIs has also led to the advent of a novel class of adverse events that differ from those of classic chemotherapeutics and are more reminiscent of autoimmune diseases, the immune-related adverse events (IRAEs). Herein, we performed an insight of the main IRAEs associated with ICIs, focusing on gastroenterological IRAEs and specifically on checkpoint inhibitor colitis, which represents the most widely reported IRAE to date. We comprehensively dissected the current evidence regarding pathogenesis, diagnosis, and management of ICIs-induced colitis, touching upon also on innovative therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsColitisHumansImmunotherapyNeoplasms

Stichwörter der Autor:innen

colitisgut microbiotaimmune checkpoint inhibitorsimmune systemimmuno-related adverse effects

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • UOS Malattie Infiammatorie Croniche Intestinali, Centro di Malattie dell'Apparato Digerente (CEMAD), Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, 00168, Italy.
  • UOC di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, 00168, Italy.
  • Department of Pathology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, 00168, Italy.
  • Department of Medicine and Ageing Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, 66100, Italy.
  • Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, 66100, Italy.

ORCID-Profile: Federica Di Vincenzo, Valentina Petito, Franco Scaldaferri

Zitieren

APA

Del Gaudio, A., Di Vincenzo, F., Petito, V., Giustiniani, M. C., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. R. (2024). Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases, 30(6), 1018-1031. https://doi.org/10.1093/ibd/izad229

Vancouver

Del Gaudio A, Di Vincenzo F, Petito V, Giustiniani MC, Gasbarrini A, Scaldaferri F, et al. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases. 2024;30(6):1018-1031. doi:10.1093/ibd/izad229

BibTeX
@article{DelGaudio2024,
  author = {Del Gaudio, Angelo and Di Vincenzo, Federica and Petito, Valentina and Giustiniani, Maria Cristina and Gasbarrini, Antonio and Scaldaferri, Franco and Lopetuso, Loris Riccardo},
  title = {Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {6},
  pages = {1018--1031},
  doi = {10.1093/ibd/izad229}
}
Kostenlos starten →